Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

FHS
July 24, 2024
10:40 am

Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer.

FDA is still struggling to inspect clinical research sites, watchdog finds

The U.S. Food and Drug Administration’s oversight of clinical research in hospitals and clinics has fallen considerably in recent years, due to disruptions caused by

March 26, 2024

U.S. drug shortages have reached a decade high and are lasting longer, too

Amid rising concern over prescription drug shortages, a new report finds that the number of shortages has increased over the past decade, most are lasting

June 4, 2024

Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease

A growing body of data show that South Asians are at greater risk of developing heart disease than white people, and they tend to get

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.